Suspension of trading

Income Statement Axonics, Inc.

Stocks

AXNX

US05465P1012

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 16:00:00 2024-11-14 EST			5-day change	1st Jan Change
70.98 ^USD	+0.75%		-.--%	-

24-11-18	Axonics, Inc.(NasdaqGS:AXNX) dropped from S&P Healthcare Equipment Select Industry Index	CI
24-11-18	Axonics, Inc.(NasdaqGS:AXNX) dropped from S&P Global BMI Index	CI

4.ALaJUvUnmO0SYR1Vj599gYbq8WRb_pKMjk4E-g-tp_I.avToZ7gV9N0qVHVtt9AV0cCsoC8StvDa73pWomv534Fm7N83o2vhsj8SLQ

Published financial data: AXONICS, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	13.82M	112M	180M	274M	366M
Total Revenues	13.82M	112M	180M	274M	366M
Cost of Goods Sold, Total	6.49M	44.44M	64.57M	76.04M	91.82M
Gross Profit	7.33M	67.09M	116M	198M	275M
Selling General & Admin Expenses, Total	67.75M	91.68M	139M	196M	235M
R&D Expenses	20.18M	29.17M	37.3M	34.41M	34.89M
Amortization of Goodwill and Intangible Assets - (IS)	-	-	7.24M	9.38M	9.06M
Other Operating Expenses, Total	87.93M	121M	183M	240M	279M
Operating Income	-80.6M	-53.76M	-67.39M	-42.08M	-4.71M
Interest Expense, Total	-2.31M	-1.87M	-7.43M	-2.43M	-
Interest And Investment Income	2.97M	761K	40K	5.13M	17.31M
Net Interest Expenses	665K	-1.11M	-7.39M	2.7M	17.31M
Other Non Operating Income (Expenses)	-	-	-	-	-
EBT, Excl. Unusual Items	-79.93M	-54.87M	-74.78M	-39.39M	12.6M
Merger & Related Restructuring Charges	-	-	-4.41M	-22.56M	-5.9M
Gain (Loss) On Sale Of Assets	-	-41K	-91K	-69K	-1K
Asset Writedown	-	-	-	-300K	-
In Process R&D Expenses	-	-	-	-	-15.45M
EBT, Incl. Unusual Items	-79.93M	-54.91M	-79.28M	-62.32M	-8.74M
Income Tax Expense	1K	1K	782K	-2.62M	-2.66M
Earnings From Continuing Operations	-79.94M	-54.92M	-80.07M	-59.7M	-6.09M
Net Income to Company	-79.94M	-54.92M	-80.07M	-59.7M	-6.09M
Net Income - (IS)	-79.94M	-54.92M	-80.07M	-59.7M	-6.09M
Net Income to Common Incl Extra Items	-79.94M	-54.92M	-80.07M	-59.7M	-6.09M
Net Income to Common Excl. Extra Items	-79.94M	-54.92M	-80.07M	-59.7M	-6.09M
Per Share Items
Net EPS - Basic	-2.8	-1.48	-1.86	-1.28	-0.12
Basic EPS - Continuing Operations	-2.8	-1.48	-1.86	-1.28	-0.12
Basic Weighted Average Shares Outstanding	28.57M	36.98M	43.07M	46.68M	49.08M
Net EPS - Diluted	-2.8	-1.48	-1.86	-1.28	-0.12
Diluted EPS - Continuing Operations	-2.8	-1.48	-1.86	-1.28	-0.12
Diluted Weighted Average Shares Outstanding	28.57M	36.98M	43.07M	46.68M	49.08M
Normalized Basic EPS	-1.75	-0.93	-1.09	-0.53	0.16
Normalized Diluted EPS	-1.75	-0.93	-1.09	-0.53	0.16
Supplemental Items
EBITDA	-79.41M	-52.02M	-58.27M	-30.36M	7.78M
EBITA	-80.5M	-53.66M	-60.19M	-32.7M	4.35M
EBIT	-80.6M	-53.76M	-67.39M	-42.08M	-4.71M
EBITDAR	-78.06M	-49.75M	-55.88M	-27.95M	9.5M
Effective Tax Rate - (Ratio)	-0	-0	-0.99	4.2	30.38
Current Domestic Taxes	-	-	211K	76K	409K
Current Foreign Taxes	-	-	26K	174K	1.43M
Total Current Taxes	-	-	237K	250K	1.84M
Deferred Domestic Taxes	-	-	-539K	-	-
Deferred Foreign Taxes	-	-	1.08M	-2.87M	-4.5M
Total Deferred Taxes	-	-	545K	-2.87M	-4.5M
Normalized Net Income	-49.96M	-34.3M	-46.74M	-24.62M	7.88M
Supplemental Operating Expense Items
Advertising Expense	-	2.9M	7.8M	20.6M	19.5M
Selling and Marketing Expenses	48.67M	66.13M	106M	156M	190M
General and Administrative Expenses	17.73M	23.29M	30.39M	37.52M	44.02M
Research And Development Expense From Footnotes	20.18M	29.17M	37.3M	34.41M	50.33M
Net Rental Expense, Total	1.35M	2.26M	2.39M	2.41M	1.73M
Imputed Operating Lease Interest Expense	1.02M	1.19M	6.78M	4.81M	-
Imputed Operating Lease Depreciation	329K	1.07M	-4.38M	-2.4M	-
Stock-Based Comp., R&D Exp. (Total)	1.72M	3.46M	5.98M	6.73M	9.36M
Stock-Based Comp., S&M Exp. (Total)	3.04M	5.79M	11.1M	17.32M	23.49M
Stock-Based Comp., G&A Exp. (Total)	3.95M	5.85M	8.08M	7.96M	11.69M
Total Stock-Based Compensation	8.72M	15.1M	25.16M	32.02M	44.54M

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	171M	241M	221M	239M	105M
Short Term Investments	12.59M	-	-	118M	240M
Total Cash And Short Term Investments	184M	241M	221M	357M	345M
Accounts Receivable, Total	7.88M	18.27M	29.04M	44.82M	57.24M
Other Receivables	900K	-	-	-	-
Total Receivables	8.78M	18.27M	29.04M	44.82M	57.24M
Inventory	15.66M	63.06M	64.95M	55.76M	79.94M
Prepaid Expenses	3.57M	5.44M	6.45M	7.28M	9.28M
Total Current Assets	212M	328M	321M	465M	491M
Gross Property Plant And Equipment	10.31M	17.24M	19.56M	20.53M	44.12M
Accumulated Depreciation	-3.06M	-3.82M	-5.54M	-7.54M	-10.86M
Net Property Plant And Equipment	7.25M	13.43M	14.02M	13M	33.26M
Goodwill	-	-	106M	94.41M	99.42M
Other Intangibles, Total	311K	196K	106M	86.25M	81.38M
Other Long-Term Assets, Total	584K	636K	634K	613K	14.45M
Total Assets	220M	342M	548M	659M	720M
Liabilities
Accounts Payable, Total	5.88M	10.66M	7.65M	9.07M	18.45M
Accrued Expenses, Total	5.55M	12.63M	17.85M	22.02M	25.59M
Current Portion of Long-Term Debt	-	21.11M	-	-	-
Current Portion of Leases	602K	1.28M	1.37M	1.56M	1.78M
Other Current Liabilities	-	-	-	32.6M	-
Total Current Liabilities	12.03M	45.68M	26.87M	65.25M	45.82M
Long-Term Debt	20.34M	-	-	-	-
Long-Term Leases	4.45M	9.15M	9.05M	7.56M	25.84M
Deferred Tax Liability Non Current	-	-	19.22M	16.41M	10.7M
Other Non Current Liabilities	-	-	10.37M	-	-
Total Liabilities	36.82M	54.84M	65.51M	89.21M	82.36M
Preferred Stock Convertible	-	-	-	-	-
Total Preferred Equity	-	-	-	-	-
Common Stock, Total	3K	4K	5K	5K	5K
Additional Paid In Capital	363M	522M	804M	970M	1.03B
Retained Earnings	-180M	-234M	-315M	-374M	-380M
Comprehensive Income and Other	-428K	-431K	-6.56M	-25.15M	-15.87M
Total Common Equity	183M	287M	482M	570M	638M
Total Equity	183M	287M	482M	570M	638M
Total Liabilities And Equity	220M	342M	548M	659M	720M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	34.29M	41.52M	46.96M	49.96M	51M
ECS Total Common Shares Outstanding	34.11M	39.93M	46.33M	49.55M	50.77M
Book Value / Share	5.36	7.2	10.41	11.51	12.56
Tangible Book Value	183M	287M	270M	389M	457M
Tangible Book Value Per Share	5.36	7.19	5.84	7.86	9
Total Debt	25.39M	31.54M	10.42M	9.12M	27.62M
Net Debt	-158M	-210M	-210M	-348M	-317M
Debt Equivalent Oper. Leases	10.77M	18.12M	19.14M	19.31M	13.84M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	7.16M	17.46M	15.35M	19.66M	20.54M
Inventories - Work In Process, Total	1.5M	3.5M	2.8M	5.7M	10.5M
Inventories - Finished Goods, Total	7M	42.1M	46.8M	30.4M	48.9M
Machinery, Total	4.43M	6.26M	7.96M	9.47M	11M
Full Time Employees	302	416	517	610	797
Accumulated Allowance for Doubtful Accounts (Supple)	75K	465K	355K	321K	442K

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	-79.94M	-54.92M	-80.07M	-59.7M	-6.09M
Depreciation & Amortization - CF	1.49M	2.54M	2.93M	3.34M	4.32M
Amortization of Goodwill and Intangible Assets - (CF)	100K	100K	7.2M	9.38M	9.06M
Depreciation & Amortization, Total	1.59M	2.64M	10.13M	12.72M	13.39M
Amortization of Deferred Charges, Total - (CF)	873K	774K	4.99M	-	-
(Gain) Loss From Sale Of Asset	-	41K	91K	69K	1K
Asset Writedown & Restructuring Costs	-	-	-	-	15.45M
Stock-Based Compensation (CF)	8.72M	15.1M	25.16M	32.02M	44.54M
Provision and Write-off of Bad Debts	75K	390K	-122K	-34K	121K
Other Operating Activities, Total	-400K	-735K	2.32M	21.05M	-3.31M
Change In Accounts Receivable	-7.53M	-10.78M	-9M	-15.97M	-12.43M
Change In Inventories	-11.99M	-47.35M	-1.11M	8.42M	-25.75M
Change In Accounts Payable	2.45M	4.78M	-2.86M	1.47M	9.01M
Change in Other Net Operating Assets	2.69M	6.32M	3.16M	3.15M	-36.94M
Cash from Operations	-83.45M	-83.74M	-47.31M	3.19M	-2.02M
Capital Expenditure	-1.34M	-2.94M	-2.26M	-2.22M	-3.55M
Cash Acquisitions	-	-	-141M	-	-
Investment in Marketable and Equity Securities, Total	46.63M	12.59M	-	-118M	-113M
Cash from Investing	45.29M	9.65M	-143M	-120M	-117M
Long-Term Debt Issued, Total	-	-	75M	-	-
Total Debt Issued	-	-	75M	-	-
Long-Term Debt Repaid, Total	-	-	-101M	-	-
Total Debt Repaid	-	-	-101M	-	-
Issuance of Common Stock	118M	153M	208M	134M	4.25M
Repurchase of Common Stock	-	-	-	-	-
Issuance of Preferred Stock	-	-	-	-	-
Other Financing Activities, Total	-7.14M	-9.01M	-11.38M	-192K	-7.63M
Cash from Financing	111M	144M	171M	134M	-3.38M
Foreign Exchange Rate Adjustments	-12K	-3K	-508K	1.16M	979K
Net Change in Cash	72.78M	70.1M	-20.3M	17.97M	-121M
Supplemental Items
Cash Interest Paid	1.44M	1.1M	2.18M	1K	69K
Cash Income Tax Paid (Refund)	1K	1K	1K	667K	255K
Levered Free Cash Flow	-55.85M	-66.1M	-20.21M	45.45M	-6.82M
Unlevered Free Cash Flow	-55.28M	-65.7M	-20.56M	46.97M	-6.82M
Change In Net Working Capital	13.88M	46.9M	11.46M	-30.76M	58.24M
Net Debt Issued / Repaid	-	-	-26.12M	-	-

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	-25.72	-11.96	-9.46	-4.36	-0.43
Return on Total Capital	-26.85	-12.74	-10.38	-4.91	-0.47
Return On Equity %	-49	-23.35	-20.8	-11.34	-1.01
Return on Common Equity	-49	-23.35	-20.8	-11.34	-1.01
Margin Analysis
Gross Profit Margin %	53.04	60.15	64.18	72.22	74.94
SG&A Margin	490.22	82.2	76.86	71.6	64.23
EBITDA Margin %	-574.59	-46.64	-32.32	-11.09	2.12
EBITA Margin %	-582.48	-48.11	-33.39	-11.95	1.19
EBIT Margin %	-583.21	-48.2	-37.38	-15.38	-1.29
Income From Continuing Operations Margin %	-578.4	-49.24	-44.41	-21.81	-1.66
Net Income Margin %	-578.4	-49.24	-44.41	-21.81	-1.66
Net Avail. For Common Margin %	-578.4	-49.24	-44.41	-21.81	-1.66
Normalized Net Income Margin	-361.5	-30.75	-25.92	-8.99	2.15
Levered Free Cash Flow Margin	-404.13	-59.26	-11.21	16.61	-1.86
Unlevered Free Cash Flow Margin	-400	-58.91	-11.4	17.16	-1.86
Asset Turnover
Asset Turnover	0.07	0.4	0.41	0.45	0.53
Fixed Assets Turnover	2.1	10.79	13.14	20.26	15.84
Receivables Turnover (Average Receivables)	3.33	8.53	7.62	7.41	7.18
Inventory Turnover (Average Inventory)	0.67	1.13	1.01	1.26	1.35
Short Term Liquidity
Current Ratio	17.59	7.18	11.96	7.13	10.73
Quick Ratio	15.99	5.68	9.3	6.16	8.78
Operating Cash Flow to Current Liabilities	-6.94	-1.83	-1.76	0.05	-0.04
Days Sales Outstanding (Average Receivables)	109.68	42.9	47.89	49.25	50.84
Days Outstanding Inventory (Average Inventory)	543.62	324.13	361.78	289.72	269.71
Average Days Payable Outstanding	92.04	32.96	50.29	45.65	43.3
Cash Conversion Cycle (Average Days)	561.26	334.07	359.39	293.32	277.25
Long Term Solvency
Total Debt/Equity	13.87	10.98	2.16	1.6	4.33
Total Debt / Total Capital	12.18	9.89	2.11	1.57	4.15
LT Debt/Equity	13.54	3.19	1.88	1.33	4.05
Long-Term Debt / Total Capital	11.89	2.87	1.84	1.3	3.88
Total Liabilities / Total Assets	16.75	16.02	11.96	13.53	11.44
EBIT / Interest Expense	-34.91	-28.69	-9.08	-17.29	-
EBITDA / Interest Expense	-33.81	-26.55	-7.52	-11.48	-
(EBITDA - Capex) / Interest Expense	-34.39	-28.12	-7.83	-12.4	-
Total Debt / EBITDA	-0.33	-0.63	-0.19	-0.33	2.91
Net Debt / EBITDA	2.03	4.21	3.77	12.45	-33.39
Total Debt / (EBITDA - Capex)	-0.32	-0.6	-0.18	-0.3	4.64
Net Debt / (EBITDA - Capex)	1.99	3.98	3.62	11.54	-53.29
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	1.85K	707.05	61.64	51.81	33.86
Gross Profit, 1 Yr. Growth %	1.99K	815.29	72.48	70.82	38.9
EBITDA, 1 Yr. Growth %	154.59	-34.49	12.01	-45.31	-125.61
EBITA, 1 Yr. Growth %	151.27	-33.34	12.18	-43.04	-113.31
EBIT, 1 Yr. Growth %	150.8	-33.3	25.36	-34.9	-88.8
Earnings From Cont. Operations, 1 Yr. Growth %	146.08	-31.3	45.8	-25.44	-89.8
Net Income, 1 Yr. Growth %	146.08	-31.3	45.8	-25.44	-89.8
Normalized Net Income, 1 Yr. Growth %	146.09	-31.35	36.28	-45.32	-132
Diluted EPS Before Extra, 1 Yr. Growth %	-39.72	-46.93	25.18	-31.21	-90.3
Accounts Receivable, 1 Yr. Growth %	1.75K	131.88	58.97	54.31	27.73
Inventory, 1 Yr. Growth %	326.33	302.71	2.99	-14.14	43.35
Net Property, Plant and Equip., 1 Yr. Growth %	23.16	85.29	4.37	-7.26	155.89
Total Assets, 1 Yr. Growth %	27.87	55.67	60.12	20.33	9.19
Tangible Book Value, 1 Yr. Growth %	27.89	57.19	-5.82	44	17.28
Common Equity, 1 Yr. Growth %	27.73	57.03	67.88	18.18	11.83
Cash From Operations, 1 Yr. Growth %	166.03	0.35	-43.51	-106.75	-163.18
Capital Expenditures, 1 Yr. Growth %	9.04	119.42	-23.04	-1.68	59.69
Levered Free Cash Flow, 1 Yr. Growth %	146.65	18.35	-69.43	-345.79	-115
Unlevered Free Cash Flow, 1 Yr. Growth %	149.66	18.85	-68.71	-349.3	-114.51
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	939.08	1.16K	261.19	56.65	42.55
Gross Profit, 2 Yr. CAGR %	2.61K	1.28K	297.33	71.65	54.03
EBITDA, 2 Yr. CAGR %	113.33	29.14	-14.34	-23.6	-62.58
EBITA, 2 Yr. CAGR %	111.04	29.42	-13.53	-21.92	-72.47
EBIT, 2 Yr. CAGR %	110.59	29.34	-8.56	-11.52	-73
Earnings From Cont. Operations, 2 Yr. CAGR %	110.38	30.02	0.08	4.26	-72.43
Net Income, 2 Yr. CAGR %	110.38	30.02	0.08	4.26	-72.43
Normalized Net Income, 2 Yr. CAGR %	110.76	29.97	-3.28	-15.28	-58.17
Diluted EPS Before Extra, 2 Yr. CAGR %	-36.96	-43.44	-18.49	-7.2	-74.17
Accounts Receivable, 2 Yr. CAGR %	-	554.12	92	56.62	40.39
Inventory, 2 Yr. CAGR %	218.77	314.35	103.65	-5.96	10.94
Net Property, Plant and Equip., 2 Yr. CAGR %	110.86	51.07	39.06	-1.61	54.05
Total Assets, 2 Yr. CAGR %	173.38	41.09	57.88	38.81	14.62
Tangible Book Value, 2 Yr. CAGR %	65.18	41.79	21.67	16.46	29.96
Common Equity, 2 Yr. CAGR %	65.99	41.62	62.36	40.85	14.96
Cash From Operations, 2 Yr. CAGR %	114.28	63.39	-24.71	-80.48	-79.36
Capital Expenditures, 2 Yr. CAGR %	13.52	54.68	29.95	-13.02	25.3
Levered Free Cash Flow, 2 Yr. CAGR %	113.03	70.85	-39.85	-17.08	-39.29
Unlevered Free Cash Flow, 2 Yr. CAGR %	112.06	72.25	-39.02	-15.45	-39.85
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	855.14	534.14	170.56	48.65
Gross Profit, 3 Yr. CAGR %	-	1.79K	590.82	199.88	59.95
EBITDA, 3 Yr. CAGR %	67.63	43.92	23.16	-27.42	-46.93
EBITA, 3 Yr. CAGR %	66.73	43.72	23.4	-25.94	-56.71
EBIT, 3 Yr. CAGR %	66.43	43.55	28	-19.47	-55.58
Earnings From Cont. Operations, 3 Yr. CAGR %	66.24	44.87	35.08	-9.27	-51.96
Net Income, 3 Yr. CAGR %	66.24	44.87	35.08	-9.27	-51.96
Normalized Net Income, 3 Yr. CAGR %	66.24	45.01	32.04	-21.02	-38.76
Diluted EPS Before Extra, 3 Yr. CAGR %	-32.32	-40.48	-26.29	-22.97	-56.29
Accounts Receivable, 3 Yr. CAGR %	-	-	308.2	78.51	46.33
Inventory, 3 Yr. CAGR %	-	244.6	160.52	52.71	8.23
Net Property, Plant and Equip., 3 Yr. CAGR %	83.79	101.96	33.55	21.5	35.3
Total Assets, 3 Yr. CAGR %	172.56	126.6	47.17	44.22	28.13
Tangible Book Value, 3 Yr. CAGR %	53.93	62.47	23.71	28.7	16.73
Common Equity, 3 Yr. CAGR %	54.7	62.95	49.88	46.05	30.42
Cash From Operations, 3 Yr. CAGR %	68.85	66.4	14.67	-66.31	-71.13
Capital Expenditures, 3 Yr. CAGR %	66.12	41.41	22.57	18.41	6.51
Levered Free Cash Flow, 3 Yr. CAGR %	-	75.13	-3.73	-6.64	-53.11
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	74.84	-2.45	-5.28	-53.01
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-	363.46	249.06
Gross Profit, 5 Yr. CAGR %	-	-	-	623.08	279.02
EBITDA, 5 Yr. CAGR %	-	-	28.15	11.72	-24.26
EBITA, 5 Yr. CAGR %	-	-	28.22	12.59	-32.92
EBIT, 5 Yr. CAGR %	-	-	30.98	18.29	-31.89
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	35.7	27.01	-28.46
Net Income, 5 Yr. CAGR %	-	-	35.7	27.01	-28.46
Normalized Net Income, 5 Yr. CAGR %	-	-	33.86	16.96	-17.25
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-27.1	-28.91	-51.54
Accounts Receivable, 5 Yr. CAGR %	-	-	-	-	166.35
Inventory, 5 Yr. CAGR %	-	-	-	104.98	85.16
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	64.39	51.47	41.4
Total Assets, 5 Yr. CAGR %	-	-	119.09	86.26	33.17
Tangible Book Value, 5 Yr. CAGR %	-	-	40.11	42.21	26.17
Common Equity, 5 Yr. CAGR %	-	-	57.72	53.72	34.79
Cash From Operations, 5 Yr. CAGR %	-	-	22.24	-29.39	-42.24
Capital Expenditures, 5 Yr. CAGR %	-	-	50.57	16.43	23.65
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	29.86	-21.35
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	30.75	-20.99